Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (3)
  • Autophagy
    (3)
  • E3 Ligase Ligand-Linker Conjugates
    (3)
  • PROTAC Linker
    (2)
  • Androgen Receptor
    (1)
  • Epigenetic Reader Domain
    (1)
  • Histone Acetyltransferase
    (1)
  • NMDAR
    (1)
  • PROTACs
    (1)
  • Others
    (6)
TargetMol | Tags By ResearchField
  • Cancer
    (7)
  • Immune System
    (1)
  • Infection
    (1)
  • Inflammation
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

T3969

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    9
    TargetMol | All_Pathways
  • PROTAC Products
    6
    TargetMol | PROTAC
I-CBP112
T39691640282-31-0
I-CBP112 is a specific and potent acetyl-lysine competitive protein-protein interaction inhibitor targeting the CBP/p300 bromodomains.
  • $29
In Stock
Size
QTY
TargetMol | Citations Cited
Benzyl-PEG24-alcohol
Benzyl-PEG24-alcohol
T396902218463-19-3
Benzyl-PEG24-alcohol is a PEG-based linker for PROTACs, connecting two essential ligands crucial for PROTAC molecule formation, facilitating selective protein degradation via the ubiquitin-proteasome system within cells.
  • Inquiry Price
Inquiry
Size
QTY
Benzyl-PEG24-MS
Benzyl-PEG24-MS
T396912218463-20-6
Benzyl-PEG24-MS is a PEG-based linker for PROTACs that joins two essential ligands, crucial for forming PROTAC molecules, enabling selective protein degradation by leveraging the ubiquitin-proteasome system within cells.
  • Inquiry Price
Inquiry
Size
QTY
Polyketide synthase 13-IN-3
T396932221801-50-7
Polyketide synthase 13-IN-3 (compound 41) is a potent inhibitor of polyketide synthase 13, with a minimum inhibitory concentration (MIC) range of 0.0625-0.125 μg/mL against the M. tuberculosis strain H37Rv.
  • $970
Inquiry
Size
QTY
GluN2B receptor modulator-1
T396942222010-71-9
GluN2B receptor modulator-1 is a potent and selective allosteric negative modulator of the GluN2B subunit of NMDA receptors, exhibiting an IC50 value of 31 nM, enabling spcific modulation of subunit-specific allosteric control over the transmembrane ion channel pores of the NMDARs. providing a valuable tool in neuropharmacology and receptor-specific mechanisms relevant in the study of neurological diseases.
  • $397
In Stock
Size
QTY
ARD-2128
T396952222111-87-5
ARD-2128 is a highly potent, orally bioavailable PROTAC (proteolysis-targeting chimera) that degrades the androgen receptor (AR), effectively reducing AR protein levels, suppressing AR-regulated gene expression in tumor tissues, and inhibiting tumor growth without evident toxicity. This compound holds promise for prostate cancer research.
  • $228
In Stock
Size
QTY
Thalidomide-Piperazine 5-fluoride
T396962222114-22-7
Thalidomide-Piperazine 5-fluoride is a compound synthesized as an E3 ligase ligand-linker conjugate, incorporating a cereblon ligand derived from Thalidomide and utilizing a linker commonly employed in PROTAC technology.
  • Inquiry Price
7-10 days
Size
QTY
Thalidomide-piperazine-Boc
T396972222114-64-7
Thalidomide-piperazine-Boc, an intermediate used in the synthesis of BCL6 PROTAC, targets the B-cell lymphoma 6 protein.
  • $33
7-10 days
Size
QTY
Thalidomide-O-C8-Boc
Thalidomide-O-C8-Boc
T396992225148-52-5
Thalidomide-O-C8-Boc is a Cereblon ligand derived from Thalidomide, primarily employed in the recruitment of CRBN protein. This ligand can be linked to a protein ligand via a linker to create PROTACs.
  • $996
Inquiry
Size
QTY